Health Services Stocks On The Rise With Help From 3 Stocks
Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer.
Two out of the three major indices are trading lower today with the
Dow Jones Industrial Average
(
^DJI
) trading down 41 points (-0.2%) at 18,075 as of Tuesday, March 24, 2015, 12:55 PM ET. The NYSE advances/declines ratio sits at 1,371 issues advancing vs. 1,586 declining with 175 unchanged.
The Health Services industry currently sits up 0.2% versus the S&P 500, which is down 0.2%. A company within the industry that increased today was
(
), up 2.5%.
TheStreet would like to highlight 3 stocks pushing the industry higher today:
3.
Fresenius Medical Care AG & Co. KGaA
(
) is one of the companies pushing the Health Services industry higher today. As of noon trading, Fresenius Medical Care AG & Co. KGaA is up $0.34 (0.8%) to $42.22 on average volume. Thus far, 72,315 shares of Fresenius Medical Care AG & Co. KGaA exchanged hands as compared to its average daily volume of 143,700 shares. The stock has ranged in price between $41.90-$42.29 after having opened the day at $41.95 as compared to the previous trading day's close of $41.88.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Fresenius Medical Care AG & Co. KGaA, a kidney dialysis company, provides dialysis care services related to the dialysis treatment a patient receives with end stage renal disease (ESRD); and other health care services. Fresenius Medical Care AG & Co. KGaA has a market cap of $25.2 billion and is part of the health care sector. Shares are up 12.8% year-to-date as of the close of trading on Monday. Currently there are 2 analysts who rate Fresenius Medical Care AG & Co. KGaA a buy, 1 analyst rates it a sell, and 5 rate it a hold.
TheStreet Ratings rates
Fresenius Medical Care AG & Co. KGaA
as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, solid stock price performance and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income. Get the full
Fresenius Medical Care AG & Co. KGaA Ratings Report
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
2. As of noon trading,
(
) is up $9.68 (15.8%) to $71.11 on heavy volume. Thus far, 1.6 million shares of Abiomed exchanged hands as compared to its average daily volume of 467,400 shares. The stock has ranged in price between $66.60-$73.50 after having opened the day at $66.66 as compared to the previous trading day's close of $61.43.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
ABIOMED, Inc. provides medical devices in circulatory support and continuum of care in heart recovery to acute heart failure patients. Abiomed has a market cap of $2.5 billion and is part of the health care sector. Shares are up 61.4% year-to-date as of the close of trading on Monday. Currently there are 4 analysts who rate Abiomed a buy, 1 analyst rates it a sell, and 4 rate it a hold.
TheStreet Ratings rates
Abiomed
as a
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, expanding profit margins, good cash flow from operations and compelling growth in net income. We feel these strengths outweigh the fact that the company is trading at a premium valuation based on our review of its current price compared to such things as earnings and book value. Get the full
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
1. As of noon trading,
(
) is up $1.13 (0.9%) to $129.55 on average volume. Thus far, 666,303 shares of Cigna exchanged hands as compared to its average daily volume of 1.4 million shares. The stock has ranged in price between $128.32-$130.02 after having opened the day at $128.52 as compared to the previous trading day's close of $128.42.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
Cigna Corporation, a health services organization, provides insurance and related products and services in the United States and internationally. Cigna has a market cap of $33.2 billion and is part of the health care sector. Shares are up 24.8% year-to-date as of the close of trading on Monday. Currently there are 8 analysts who rate Cigna a buy, no analysts rate it a sell, and 6 rate it a hold.
TheStreet Ratings rates
Cigna
as a
. The company's strengths can be seen in multiple areas, such as its solid stock price performance, impressive record of earnings per share growth, revenue growth, largely solid financial position with reasonable debt levels by most measures and notable return on equity. We feel these strengths outweigh the fact that the company shows weak operating cash flow. Get the full
now.
EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.
If you are interested in one of these 3 stocks, ETFs may be of interest. Investors who are bullish on the health services industry could consider
Health Care Select Sector SPDR
(
) while those bearish on the health services industry could consider
ProShares Ultra Short Health Care
(
).
null